Beating Cancer with Natural Plant Sources
Poonam
Gupta*, Mohd. Yaqub Khan, Vikas Kumar Verma, Ashish Pathak
Saroj Institute of Technology & Management,
Ahimamau , P.O. Arjunganj ,
Sultanpur Road, Lucknow-226002, Uttar Pradesh, India
*Corresponding Author E-mail: poonam.gupta213@gmail.com
ABSTRACT:
Medicinal plants
continue to play a central role in the healthcare system of large proportions
of the world’s population. This is particularly true in developing countries,
where herbal medicine has a long and uninterrupted history of use. Continuous
usage of herbal medicine by a large proportion of the population in the
developing countries is largely due to the high cost of Western pharmaceuticals
and healthcare. Every year, millions of people are diagnosed with cancer,
leading to death in a majority of the cases. Specific part of it is formulated
into suitable preparations compressed as tablets or made into pills, used to
make infusions, extracts, tinctures, etc., or mixed with excipients
to make lotions, ointments, creams, etc. Few herbal drugs are subject to
legislative control. The plant based drug discovery resulted mainly in the
development of anticancer agents including plants (vincristine,
vinblastine, etoposide, paclitaxel, camptothecin, topotecan and irinotecan). Beside
this there is numerous agents identified from fruits and vegetables can used in
anticancer therapy. The agents include curcumin (turmeric),
resveratrol (red grapes, peanuts and berries), genistein (soybean), diallyl
sulfide, S-allyl cysteine (allium), allicin (garlic), lycopene (tomato), capsaicin (red chilli),
diosgenin, 6-gingerol (ginger), ellagic
acid (pomegranate), ursolic acid (apple, pears), silymarin (milk thistle), anethol,
catechins, eugenol,
indole-3-carbinol, limonene, beta carotene, and dietary fiber. In this review
active principle derived from natural products are offering a great opportunity
to evaluate not only totally new chemical classes of anticancer agents, but
also novel lead compound and potentially relevant mechanisms of action.
KEY WORDS: Herbal medicine, Pharmaceuticals,
Healthcare, Infusions, Extracts, Tinctures, Anticancer agents
INTRODUCTION:
The history of
plant as source of anti-cancer agents started in earnest in the 1950s with the
discovery and development of the vinca alkaloids (vinblastine and vincristine) and
the isolation of the cytotoxic podophyllotoxins.
Vinca alkaloid was responsible for an increase in the
cure rates for Hodgkin’s disease and some forms of leukemia. Vincristine inhibits microtubule assembly, inducing tubulin selfassociation into
coiled spiral aggregates. Etoposide is an epipodophyllotoxin, derived from the mandrake plant Podophyllum peltatum and the wild
chervil Podophyllum emodi.
It has also significant activity against small-cell lung carcinoma. Etoposide is a topoisomerase II
inhibitor, stabilizing enzyme–DNA cleavable complexes leading to DNA breaks.
The taxanes paclitaxel and docetaxel has been show antitumor activity against breast,
ovarian and other tumor types in the clinic trial. Paclitaxel
stabilizes microtubules and leading to mitotic arrest. In addition, the camptothecin derivatives irinotecan
and topotecan, have shown significant antitumor activity against
colorectal and ovarian cancer respectively. These compounds were initially
obtained from the bark and wood of Nyssacea Camptotheca accuminata and act by
inhibiting topoisomerase I. The taxanes
and the camptothecins are presently approved for
human use in various countries.[1]
The Rate of Success:
The use of
non-toxic natural therapies has achieved huge successes over the past few
decades. Extensive studies have proven them to have an edge over conventional
therapies. Many of the alternative cancer hospitals are found in Mexico. For
example, Dr Contreras of the Oasis Hospital reported that his 5-year survival
rate for prostate cancer is 83% when using natural treatment compared to 73%
for conventional treatment. At the American Metabolic Institute, renowned
scientist Dr Geronimo Rubio reported success rates in reversing stage III and
IV cancers from 65 to 75%. The reversal rate for stage I and II cancers is 80%.
While the 5-year survival for ending stage cancer using conventional therapy is
9% overall, alternative cancer hospitals report that theirs is more than 30%.
While 4% of terminal cancer patients’ show no response to alternative
treatments, the other 96% can expect some benefits after a month of treatment.
There is therefore no turning back for patients who have bravely embarked on
the path of alternative treatments. Clearly, the success rate of natural
treatment is so much better than for many conventional cancer treatments. As
such, if you or your family members have cancer, you should consider all forms
of alternative treatment before deciding on which program to embark on. Today,
many patients opt for combination therapy, using both conventional and
alternative cancer treatments. This combined therapy is becoming more and more
popular as the success rates are higher. [2]
Integrating natural and conventional
therapies [3]
Human and animal
studies have shown successful and amazing results when chemotherapeutic agents
and natural compounds are used in combination. The objectives and rationale
behind combining conventional therapies with natural treatments are as follows:
1.
To
give a safer and more effective dose to reduce the negative side effects.
2.
To
help build healthy cells’ resistance to chemotherapy and radiotherapy and
increase drug accumulation in cancer cells.
3.
To
increase additive or synergistic cytotoxic effect
with chemotherapy and radiotherapy.
Table 1: PLANTS USED AS ANTI-CANCER [4,
5, 6]
S. NO |
Class |
Source |
Family |
Active
Constituent |
Mode of Action |
Site of Action |
1. |
Vinca alkaloids |
Catharanthus roseus |
Apocynaceae |
Vinblastine and Vincristine |
Inhibit the cell proliferation by affecting the microtubular
dynamics duringmitosis and this causes a
characteristic block during mitosis leading to apoptosis. |
Leukemia’s, Lymphomas,Advanced
testicular cancer, breast cancer,Lung cancer and
Kaposi’s sarcoma |
2. |
Podophyllum |
Podophyllum peltatum Linnaeus and Podophyllum emodiWallich. |
Berberidaceae |
Podo phyllotoxin, Epipodophyllotoxin |
|
Lymphomas, bronchial and testicular cancers. |
3. |
Taxanes |
Taxus brevifolia Nutt. |
Taxaceae |
Paclitaxel |
Active agents bind to the polymerized
microtubules which prevent the normal mitosis to occur and thus they arecalled anti-mitotic drugs |
Metastatic, breast, Ovarian,lung,
Prostate cancer andlymphoid malignancies |
4. |
Iso quinoline
plant alkaloid |
Hvdrastis Canadensis L. |
Ranuncufaceae |
Berberine |
Not known |
Osteosarcoma, lung, liver,prostate
and breast cancer |
5. |
Secondary
metabolite |
Colchicum autumnale |
Liliaceae |
Colchicine |
It causes mitotic arrest during cell
cycle and thus they areconsidered as potent
anti-mitotic drug both in-vitro and in-vivo. |
Leukemic and
solid tumors |
6. |
Bis-coumarin derivative |
Wikstroemia indica |
Thymelaeaceae |
Daphnoretin |
Suppression of protein and DNA synthesis |
a) Human hepatoma Hep3B cells. b)Suppression of protein and DNA
synthesis |
7. |
Cytotoxic
alkaloid |
Camptotheca acuminate. |
Combretaceae |
Camptothecin |
Inhibiting DNA Topoisomerase
I which plays a major role in various DNA functions like replication and transcription. |
Epithelial ovarian cancer ,Small cell lung cancer, Metastatic , colorectal cancer, Potential anti-tumoractivity both in vitro and invivo |
8. |
Soy Isoflavones. |
Glycine
max |
Meliaceae |
Diadzein and Genistein |
Inhibits 3A 4-mediated metabolism and
oxidative metabolism. |
Iinhibits ovarianand
breast cancers and also chemically induced cancersof
stomach, bladder, lung,prostate,
colon and blood. |
9. |
Polyphenolic compound |
Curcuma longa |
Gingerberace |
Curcumin |
Intercalates with DNA and also causes inhibition ofTopoisomerase II activity. It is also reportedthat this drug, inhibits cell growth and causesapoptosis of human hepatocellular
carcinoma HepG2 cells |
Colorectal cancer, multiple myeloma and pancreatic cancer. |
10. |
Carbazole
alkaloid |
Thevetia
peruciana |
Apocynaceae |
Ellipticine |
DNA intercalationand
inhibition oftopoisomerase II |
Various cancer
cell types |
11. |
Pneumotoxic furan derivative. |
Ipomoeca batatas |
Convolvulaceae |
4-Ipomeanol |
Cytochrome P-450-mediated conversioninto
DNA-binding metabolites |
Lung specific cancer in animal models |
12. |
Flavone derivative |
Amoora rohituka |
Maliaceae |
Flavopiridol |
Inhibits cell cycleprogression
at G1 orG2 phase. |
Colorectal, non-small celllung
cancer, renal cellcarcinoma, non-Hodgkin’slymphoma, chroniclymphocytic
leukemia, andalso solid tumors. |
13. |
Benzoquinone alkaloid |
Iridaceaelatea pallasii |
Iridaceae |
Irisquinone |
Acts as a chemosensitizer |
Good activity in transplantable rodent tumors. |
Table 2: Dosages form of Anticancer Drugs [7]
Sr.No. |
Product (INJECTION) |
Spec. |
Strengths |
1 |
Cyclophosphamide Injection |
BP,USP |
200mg, 500mg, 1gm |
2 |
Methotrexate Injection |
BP |
25mg |
3 |
Fluorouracil Injection |
BP |
50mg |
4 |
Cisplatin Injection |
BP |
1mg |
5 |
Doxorubicin Hydrochloride Injection |
BP,USP |
2mg |
6 |
Doxorubicin Hydrochloride for Injection |
BP,USP |
2mg |
7 |
Irinotecan Hydrochloride Injection |
IP |
20mg |
8 |
Carboplatin Injection |
BP |
10mg |
9 |
Vincristine Sulfate Injection |
USP |
1mg |
10 |
Gemcitabine for Injection |
USP |
200mg, 1gm |
Sr. No. |
Product
(TABLETS) |
Spec. |
Strengths |
Pack Size
(Strip) |
1 |
Tamoxifen
Citrate Tablets |
BP,USP |
10mg, 20mg |
10's |
2 |
Methotrexate Tablets |
BP |
2.5mg, 5.0mg,
7.5mg |
10's |
3 |
Bicalutamide Tablets |
USP |
50mg |
10's |
4 |
Anastrozole Tablets |
Inhouse |
1mg |
10's |
5 |
Letrozole
Tablets |
USP |
2.5mg |
10's |
6 |
Gefitinib
Tablets |
Inhouse |
250mg |
10's |
8 |
Fludarabine Phosphate Tablets |
Inhouse |
10mg |
10's |
9 |
Flutamide
Tablets |
Inhouse |
250mg |
10's |
Sr. No. |
Product
(CAPSULES) |
Spec. |
Strengths |
1 |
Hydroxyurea Capsules |
USP |
500mg |
2 |
Imatinib
Capsules |
Inhouse |
100mg, 400mg |
3 |
Temozolomide Capsules |
Inhouse |
20mg, 100mg,
250mg |
4 |
Etoposide
Capsules |
IP,USP |
50mg, 100mg |
ECONOMIC
BENEFITS AND ROLE OF PRIVATE SECTOR IN PHYTOMEDICINE [8, 9]
The interest in
natural therapies has increased international trade and attracted most
pharmaceutical companies interested in commercializing phytomedicine.
The private sector plays a crucial role in developing economic activities
relating to herbal biopro-specting, using the skills
and knowledge of local peoples and compensating them for their knowledge. In
both developing and developed countries, traditional medicine plays a
significant role in primary care and is often part of the “informal” private
sector. In the last few years developing countries have felt the increasing
pressure of what has now become known as
bioprospecting and biopiracy.
The pressure has come especially in the sector of traditional medicine. In
parts of
Asia and Africa,
80% of the population report frequent use of traditional medicine. In developed
countries, nearly 80% have used traditional medicine services. Herbal medicine,
a form of traditional medicine, is a billion dollar industry. Policies for
traditional medicine exist in over 100 countries, but regulating quality and
safety for patient use and sustaining knowledge and resources remain
challenges). Given the fact that in most countries, very little legislation is
in place, civil society groups and governments have reacted increasingly
strongly. The production, processing and sale of phytomedicine
products create employment for the producing countries .Communities are looking
for concrete short term benefits and, in most cases, monetary benefits.
Therefore, they would not be interes-ted in long
drawn out access and benefit agreements. There is a need for funding agencies
and bioprospectors to start funding the communities
or the service providers to communities to work through the process of value
addition to both potential and existing products, through a bottom up approach.
General
Toxicities of Antineoplastic / Anticancer Drugs are: [10]
·
Bone
marrow depression
·
Lymphocytopenia
·
GIT Stomatitis
·
Diarrhoea
·
Nausea
and Vomiting
·
Alopecia
·
Hyperuricaemia
·
Hair
loss
In 2012 sulforaphane or brocoli extract where at
least in 19 clinical trials. Apigenin and epigalocatechin
participated at phase II clinical trial. In 2012 there were 35 clinical trials
of different herbs effect for cancer cure in USA.
My Top
Anti-Cancer Foods [12]
Broccoli:
Cruciferous
vegetables are my top anti-cancer food, and broccoli heads the list. It is rich
in sulforaphane, an antioxidant
that helps the liver break down and destroys cancer-causing toxins.
Sulforaphane also increases the activity of liver enzymes that help to get
cancerous substances out of the body. Even better, broccoli sprouts contain 50 times more
sulforaphane than that found in regular broccoli. Broccoli sprouts also
have been shown to fight H. pylori, a type of bacteria believed to cause
stomach cancer.
Tomatoes:
This fruit is
rich in lycopene, the antioxidant that gives tomatoes
their red color. Studies have found that tomatoes reduce the risk for prostate
cancer—and also might reduce the risk for lung and stomach cancers.
Garlic:
Slice or dice
garlic clove, and a relatively inert compound called allicin
undergoes an amazing cascade of chemical changes. Nearly all allicin-generated compounds function as antioxidants that
prevent the types of cell mutations that give rise to cancer. Evidence suggests
that garlic might help protect against cancers of the colon, prostate,
esophagus, larynx, ovaries and kidneys.
Spinach:
Spinach and
other “greens,” such as chard and collard greens, are rich in antioxidants that
protect cells from the type of damage that can create cancerous mutations. One
study published in Journal of Agricultural and Food Chemistry gave spinach the
top “bioactivity index” ranking of vegeta- bles for its ability to protect against cancer.
SEVEN STEPS TO BEATING CANCER NATURALLY [13, 14]
Cancer can be
beaten naturally if you are determined. There are seven things you must do from
the natural medicine perspective to control cancer cell growth and beat it.
They reflect a complete approach to address the major cancer facts outlined
above. All seven steps are important. Do
not think that one is more important than others. You have to do all if you are
serious. Start with step 1, and move on to the next steps, one at a time, while
continue to do what the previous step requires. Take your time to conquer each
step before moving on. Most people require about three weeks per step. Beating
cancer is a marathon and not a sprint. If you can move through the seven steps
faster, it is even better.
Step 1
Starving Cancer cell:
Cancer is a
sugar-feeder. Learn to cut down the
sugar intake by up to 90% to create a low sugar environment. You do need
food for energy. Change to low glycemic index complex
carbohydrates. Cut off all soda pop, most grains, rice, and potato.
Step 2
Oxygenate your body:
Cancer cells
hate oxygen. They strive in an anaerobic environment. Moderate aerobic exercise is the easiest and cheapest way to get
oxygen on board. If you are too weak to do exercise, simple deep breathing is a
good start. Other oxygen generating modalities could be considered including
ozone and hydrogen peroxide therapy.
Step 3 Avoid
Malnutrition:
Forty percent of
cancer patients die of malnutrition. You need good nutrition, with healthy fats
and plant-based proteins to maintain nitrogen balance and muscle strength
without aggravating the cancer. The amount of calories you need is determined
by your physical activity level. It is easy to get calories in. The challenge
is to get nutritious and not empty calories into your body. Stay with organic whole foods, with plenty of green
leafy vegetables, low-glycemic fruits, and beans and
legumes for plant-based protein.
Step 4 Use
Nutritional Supplements:
Therapeutic
nutritional supplement is a cornerstone of the natural medicine because our
body simply cannot get enough of them from a regular diet. A blend of at least
30-50 nutrients is needed to:
1. Prevent mutation with therapeutic
doses of antioxidants.
2. Enhance mitochondrial function to
increase energy production.
3. Prevent cancer growth by blocking its
spread.
4. Enhance immune function to fight
existing cancer cells.
Step 5
Balance Your internal terrain:
Probiotics, enzymes, green
food, and fiber are the four
key pillars to re-balance your internal milieu and pH.
Use these every day to ensure optimum transit time, proper absorption of
nutrients from the food you take, and proper balance of good and bad bacteria.
Step 6
Balance Your Toxin Load:
Hundreds of
toxic chemicals including mercury,
lead, arsenic and cadmium have accumulated in our body through the
years. Detoxification is a process of cleaning up our ecosystem and giving it a
fresh start. The key elements are:
1. Use pure
filtered water as your only source of liquid, and drink plenty of it. There is
no substitute.
2. Enhance our
liver function with herbs such as milk thistle. Our liver is the main
detoxification organ.
3. Use chelating
agents to bind and remove unwanted metals and minerals.
4. Drink fresh
vegetable juices. Vegetable juicing floods the body with antioxidants.
Step 7 Balance Your Hormones:
Often
misunderstood and under-appreciated, hormones have a lot more to do with cancer
than we think. This is especially so with hormone-related cancers such as
breast, ovary, uterus, and prostate cancers. Maintaining a balanced hormonal
profile naturally is a key to well-being and longevity because we are flooded
in the sea of hormones.
Research about cancer
causes focuses on the following issues:
·
Agents (e.g. viruses) and events (e.g. mutations) which
cause or facilitate genetic changes in cells destined to become cancer.
·
The precise nature of the genetic damage, and the genes
which are affected by it.
The consequences of
those genetic changes on the biology of the cell, both in generating the
defining properties of a cancer cell, and in facilitating additional genetic
events which lead to further progression of the cancer. Natural medicine are attracting renewed
attention is encouraging from both practical and scientific view points, the
efficacy has proven over the long decades, but the mode of action of folk
herbal medicines and related products from nature is even more complex than
mechanistic clarification of a single bioactive factor. This is because unfractionated or partly fractionated extracts are used.
Often mixtures of different constituents are present. In any cases synergism is
most likely playing an important role. Evaluation and isolation of these
mixtures of the active constituent and their mode of action will be the challenging
task. Moreover, a potentially far-reaching observation in terms of the safety
of consuming certain herbs has been also evaluated. More flexibility will be
required of new researchers of natural products than ever before. But because
of the new tools available the rewards in terms of interest and the
contribution to society will be correspondingly greater than they have ever
been previously. There seems little question that a phytomedicine
worker will have a role to play for many more years and that pharmacognosits can look to the future with a great deal of anticipation.
Risks [16]
A common
misconception about herbalism and the use of
"natural" products in general, is that "natural" equals
safe. However many plants have chemical defense mechanisms against predators
that can have adverse or lethal effects on humans. Herbs can also have
undesirable side-effects just as pharmaceutical products can. These problems
are exacerbated by different controls over purity and inconsistent information
on dosage due to the status of herbs in the United States as dietary
supplements which are technically not supposed to have medicinal functions.
Standardization of purity and dosage is not mandated in the United States but
even products made to the same specification may differ as a result of
biochemical variations within a species of plant. Furthermore, if given in
conjunction with drugs, there is danger of 'summation', where the herb and the
drug have similar actions and add together to cause an 'overdose' or reduction in
the effects, particularly with the Cytochrome P450.
There is a danger that herbal remedies will be used in place of other medical
treatments which have been scientifically tested for safety and efficacy,
resulting in the development or worsening of a medical condition which could
have been better prevented or treated. There is also a danger that an herbal
remedy may itself cause harm which is unanticipated due to a lack of a full
understanding of its composition and biochemical effects.
CONCLUSION [17,
18]
Natural products
have been a prime source for the treatment of many forms of cancer, many of
which are consumed daily with the diet. They provide significant protection
against various cancers and many other diseases. The antioxidant medicinal
plants and their products prevent from the cancer and other diseases by
protecting cells from damage. Thus, consuming a diet rich in antioxidant
fruits, vegetables, herbs etc. will provide health-protective effects. All the natural products discussed in this
review exhibit anticancer activities.
Natural products offer a great opportunity to evaluate not only totally new
chemical classes of anticancer agents, but also novel and potentially relevant
mechanisms of action. Phytomedicine, in addition to
their traditional values, also hold great public and medical interest worldwide
as sources of nutraceuticals or novel lead compounds
for drug development. Not only herbal remedy revolution created new
opportunities but also served to stimulate research in the field of direct
relevance to human health care. The search for active phytocompounds
will be greatly advanced by the combination of various metabolomics
approaches with an array of bioactivity assays in mammalian systems to
differentiate between plant species, tissues, or phytopreparations,
and to identify novel lead compound candidates for future development.
Medicinal plants maintain the health and vitality of individuals, and also cure
various diseases, including cancer without causing toxicity. Plants derived components
have played an important role in the development of several clinically useful
anticancer agents. In a complementary development, the use of metabolomerefined herbal extracts with other biochemical
components in combination, rather than as isolated singly compounds (s), may
prove to be very useful as broader and holistic therapeutical
or pharmacological agents for avariety of human
health care application. The integration of phytomedicine
into the health system should be developed in such a way to bring harmony
between the traditional and modern system of health care with minimum threat to
each other. There may be some who might well demur at what they see as the
unchallenging prospect of working on phyto-medicines,
since much is already known.
REFERNCE:
1.
Ancuceanu,
R.V., Istudor, V., (2004). Pharmacologically active
natural compounds for lung cancer. Altern Med Rev.,9: 402-419.
2.
Deng,
F., Lu, J.J., Liu, H.Y., Lin, L.P., Ding, J., Zhang, J.S., (2011). Synthesis
and antitumor activity of novel salvicine analogues.
Chin Chem Lett.,22: 25-28.
3.
Dixon,
R.A., Ferreira, D., (2002). Molecules of interest: genistein. Phytochemistry.,60:
205-211.
4.
Kingston,
D.G.I., (2007). The shape of things to come: structural and synthetic studies
of taxol and related compounds. Phytochemistry.,68(14): 1844-1854.
5.
Sa, G.,
Das, T., Banerjee, S., Chakraborty,
J., (2010). Curcumin:
from exotic spice to modern anticancer drug.
Al Ameen J Med Sci.,3:
21-37.
6.
Okouneva,
T., Hill, B.T., Wilson, L., Jordan, M.A., (2003). The effects of vinflunine, vinorelbine, and vinblastine on centromere
dynamics. Mol Cancer Ther.,2: 427-436.
7.
Pan,
L., Chai, H., Kinghom,
A.D., (2010). The continuing search for antitumor agents from higher plants. Phytochem Lett.,3: 1-8.
8.
Ley, C.D.,
Horsmany, M.R., Kristjansen,P.E.G., (2007). Early effects ofcombretastatin-A4
disodium phosphateon tumor perfusion and interstitial
fluidpressure.
Neoplasia.,9: 108-112.
9.
Kingston,
D.G.I., (2007). The shape of things to come: structural and synthetic studies
of taxol and related compounds. Phytochemistry.,68(14): 1844-1854.
10. Dubey, K.K., Ray, A.R., Behera,
B.K., (2008). Production of demethylated colchicine through microbial transformation and scale-up
process development. Process Biochem.,43: 251-257.
11. Hazra, B., Sarma,
M.D., Sanyal, U., (2004). Separation methods of quinonoid constituents of plants used in oriental
traditional medicines. J Chromatogr B.,812: 259-275
12. Fulda, S., (2008). Betulinic
acid for cancer treatment and prevention.
Int J Mol Sci.,9:
1096-1107.
13. Cragg, G.M., Newman, D.J., (2005). Plants as a
source of anti-cancer agents. J
Ethnopharmacol.,100: 72-79.
14. Ancuceanu, R.V., Istudor,
V., (2004). Pharmacologically active natural compounds for lung cancer. Altern Med Rev.,9: 402-419.
15. Deng, F., Lu, J.J., Liu, H.Y., Lin, L.P.,
Ding, J., Zhang, J.S., (2011). Synthesis and antitumor activity of novel salvicine analogues. Chin Chem
Lett.,22: 25-28.
16. Dixon, R.A., Ferreira, D., (2002).
Molecules of interest: genistein. Phytochemistry.,60:
205-211.
17. Kingston, D.G.I., (2007). The shape of
things to come: structural and synthetic studies of taxol
and related compounds. Phytochemistry.,68(14):
1844-1854.
18. Okouneva, T., Hill, B.T., Wilson, L., Jordan, M.A.,
(2003). The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther.,2:
427-436.
Received on 26.02.2013 Accepted on 13.04.2013
© Asian Pharma
Press All Right Reserved
Asian J. Pharm.
Tech. 3(2): April-June.
2013; Page 39-44